QT
XERS icon

Quantbot Technologies’s Xeris Biopharma Holdings XERS Stock Holding History

Quantbot Technologies’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$880K Buy
111,102
+83,038
+296% +$530K 0.03% 695
2026
Q1 		$163K Sell
28,064
-49,584
-64% -$329K 0.01% 1222
2025
Q4 		$610K Buy
77,648
+8,283
+12% +$65.2K 0.02% 857
2025
Q3 		$565K Buy
69,365
+26,420
+62% +$176K 0.02% 976
2025
Q2 		$201K Sell
42,945
-11,162
-21% -$51.1K 0.01% 1236
2025
Q1 		$297K Buy
+54,107
New +$218K 0.01% 1038
2024
Q4 		– Sell
-15,425
Closed -$44K – 1883
2024
Q3 		$44K Buy
+15,425
New +$39.6K ﹤0.01% 1303
2021
Q1 		– Sell
-935
Closed -$4K – 1808
2020
Q4 		$4K Buy
935
+135
+17% +$675 ﹤0.01% 1185
2020
Q3 		$4K Buy
+800
New +$3.2K ﹤0.01% 1204

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Quantbot Technologies's XERS Position: Q2 2026 in Review

Quantbot Technologies increased its Xeris Biopharma Holdings (XERS) stake by 296% in Q2 2026, buying an estimated $530K and bringing the position to 111,102 shares worth $880K. The position accounts for 0.03% of the portfolio, ranked #695.

Quantbot Technologies first reported a position in XERS in Q3 2020 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Quantbot Technologies held 111,102 shares of Xeris Biopharma Holdings worth $880K as of Q2 2026.
  • Quantbot Technologies bought 83,038 Xeris Biopharma Holdings shares in Q2 2026, an estimated $530K.
  • Xeris Biopharma Holdings made up 0.03% of Quantbot Technologies's portfolio in Q2 2026, its #695 holding.
  • Quantbot Technologies first reported a position in Xeris Biopharma Holdings in Q3 2020 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.